Antibodies targeting GPNMB may slow Parkinson’s disease progression – Diabetes Prevention Awareness Center

Antibodies targeting GPNMB may slow Parkinson’s disease progression

Post author:admin
Post published:May 12, 2026
Post category:uncategorized
Post comments:0 Comments

Monoclonal antibodies can block a key immune‑related protein that drives the spread of brain cell damage in Parkinson’s disease (PD).

Leave a Reply Cancel reply

You must be logged in to post a comment.

Empowering individuals with knowledge, fostering healthier lifestyles, and fostering a community dedicated to diabetes awareness and prevention. Together, we’re shaping a healthier future.

Helpful Links

Subscribe To Us

By submitting via this part of the website you are granting us permission to store and process your data according to our Standard privacy policy

© 2026 Diabetes Prevention Awareness Center.